IMPORTANT SAFETY INFORMATION
AZILECT® (rasagiline tablets) is contraindicated with meperidine, tramadol, methadone, propoxyphene, dextromethorphan, St. John’s wort, cyclobenzaprine, or another (selective or non-selective) MAOI. Read More Important Safety Information
|Add-on to LD therapy||AZILECT 0.5 mg once-daily; may increase to 1 mg once-daily as needed|
|Add-on to DA monotherapy||AZILECT 1 mg once-daily|
|Monotherapy||AZILECT 1 mg once-daily|
*See full Prescribing Information for dosing in special populations.
AZILECT® (rasagiline tablets) is indicated for the treatment of Parkinson’s disease (PD).
|1.||AZILECT Prescribing Information, May 2014.|